Legend: Interesting =number_format($GLOBALS["totscache"]["RateGood"])?> Not Interesting =number_format($GLOBALS["totscache"]["RateBad"])?>
Add Another Tag/Keyword To Link
Test AltBib.Com Backup Copy Report Broken Link and Get Redirected To Backup Copy
In a number of big ways, the offline backup
is far inferior to this online version,
but it is there juuust in case we lose
free speech as we know it on the internet.
DATABASE TOTALS:6,082 Reference Links,
with 11,639 Tags/Keywords,
with 68,035 Taggings
AltBib.Com is a free, research database with articles,
documents and videos shining light on interesting topics.
Most links are to significant information 'validated' as 'true' by the Mainstream Media, sometimes buried in the final paragraphs,
which are directly referenced by the Alternative Media/New Media in creating controversial alternative analysis.
So check out some mainstream evidence and see if you naturally end up agreeing with an alternate analysis.
You can pick a tag/keyword/topic or source from the menus above to start wandering the database,
or make more complicated Custom Filters.
Or use the Search bar to type in tags or news headlines to refine your filter.
Please help this resource grow by suggesting new links, and adding tags to or rating links.
More tools launching soon...
Documents are largely from what is referenced by interesting films, Prison Planet/Infowars and the Corbett Report. This database is a quick reference and for your analysis, more independent from others' interpretations. The database includes almost all source documents and articles from these films: Loose Change (Final Cut & 2nd Edition), Fabled Enemies, The Obama Deception, End Game, Martial Law 9/11, American Dictators, Matrix of Evil, Zeitgeist: Addendum, Who Killed The Electric Car?, The World According To Monsanto, Mind The Gap, and 7/7 Ripple Effect.
San Francisco Rainwater: Radiation 181 Times Above US Drinking Water Standard Radiation from Japan rained on Berkeley, California, during recent storms at levels that exceeded drinking water standards by 181 times. A rooftop water monitoring program managed by the University of California at Berkeley’s Department of Nuclear Engineering detected substantial spikes in rain-borne iodine-131 during those torrential downpours. The levels exceeded federal drinking water thresholds, known as Maximum Contaminant Levels -- or MCLs -- by as much as 181 times or 18,100%. Iodine-131 is one of the most cancer-causing toxic radioactive isotopes spewed when nuclear power plants are in meltdown. It is being ingested by cows, which have begun passing it through into their milk and radioactivity has been detected. [Multiple Sources]
Specific Scientific Data
The iodine-131 level in the rainwater sample taken on the roof of Etcheverry Hall on the campus of UC Berkeley on March 23rd, 2011, from 9:06-18:00hrs Pacific Daylight Time (PDT) states radioactivity levels at 20.1 Becquerels per Litre (Bq/L) = 543 PicoCuries per Litre (pCi/L). The federal maximum level of iodine-131 allowed in drinking water is 3 pCi/L or 0.111 Becquerels per Litre. The sample exceeded the federal guidelines for drinking water by 181 times. The UC Berkeley researchers also discovered trace levels of iodine-131 and other radioactive isotopes, believed to have originated in Fukushima, in commercially available milk and in a local stream within California. [UC Berkeley] (Business Insider)
'Naked' scanners may increase cancer risk “While the dose would be safe if it were distributed throughout the volume of the entire body, the dose to the skin may be dangerously high,” Dr Agard said. "Ionizing radiation such as the X-rays used in these scanners have the potential to induce chromosome damage, and that can lead to cancer." (News.au.com)
Full-body scanners used on air passengers may damage human DNA And yet no such long-term safety testing has ever been conducted by a third party. There have been no clinical trials indicating that multiple exposures to such terahertz waves, accumulated over a long period of time, are safe for humans. The FDA, in particular, has never granted its approval for any such devices even though these devices clearly qualify as "medical devices." (Natural News)
Court fines OxyContin maker $634M US The maker of the narcotic painkiller OxyContin and three executives pleaded guilty Thursday to making false claims about the drug's risk of addiction, a U.S. federal prosecutor and the company said.
Purdue Pharma LP pleaded guilty in a Virginia court to felony misbranding of OxyContin with the intent to defraud. The company's president, chief lawyer and former chief medical officer also pleaded guilty to charges of misbranding — a crime of mislabelling, fraudulently promoting or marketing a drug for an unapproved use.
"With its OxyContin, Purdue unleashed a highly abusable, addictive and potentially dangerous drug on an unsuspecting and unknowing public," U.S. Attorney John Brownlee said in a release.
"For these misrepresentations and crimes, Purdue and its executives have been brought to justice."
The Stamford, Conn.-based company and executives agreed to pay $634,515,475 US in fines.
The company promoted OxyContin as being less addictive and less likely to cause withdrawal symptoms than short-acting opioid painkillers because of OxyContin's time-release formulation. The U.S. Food and Drug Administration did not approve the claims. (CBC)
More Bitter Pills For Big Pharma: Patents are expiring on blockbuster drugs, and there's not much in the pipelines -- Executives fear that Washington will get tough in the wake of the Vioxx debacle Last year, Merck & Co. made pharmaceutical history as the company that suffered the greatest agony due to a pain remedy. In September, Merck withdrew Vioxx, its $2.5 billion pain medication, after a study confirmed fears that the drug raised the risk of heart attacks.
Within weeks, Merck had plenty of company: A study linked Pfizer Inc.'s (PFE ) Celebrex to heart problems. Eli Lilly & Co. (LLY ) warned of potential liver problems with Strattera, a drug for attention-deficit hyperactivity disorder. AstraZeneca PLC (AZN ) disclosed that Iressa, a lung cancer treatment, did not extend patients' lives. And Crestor, a cholesterol-lowering drug from the same company, fell under scrutiny for potential side effects. By the end of the year, all this heat was battering pharmaceutical company valuations and misting future prospects for drug stocks.
The current year is unlikely to mark a return of robust health for the drug sector. A preliminary estimate from business information and consulting firm IMS Health (RX ) shows drug sales in the U.S. will be up 9.5% this year, to $259 billion. That's a tad better than 2004, with estimates showing sales rising 9%. But it's hardly a stellar performance: The industry hadn't posted single-digit growth since 1994. (Bloomberg)
Covert X-rays tested as security tool Department of Homeland Security spokesman Donald W. Tighe said in a statement: ''We look forward to working with the FDA and other federal, state, and local partners in evaluating what protective measures are put in place and what technologies are used, balancing security and privacy with public health." (Boston Globe)
The Truth About the Drug Companies Every day Americans are subjected to a barrage of advertising by the pharmaceutical industry. Mixed in with the pitches for a particular drug—usually featuring beautiful people enjoying themselves in the great outdoors—is a more general message. Boiled down to its essentials, it is this: “Yes, prescription drugs are expensive, but that shows how valuable they are. Besides, our research and development costs are enormous, and we need to cover them somehow. As ‘research-based’ companies, we turn out a steady stream of innovative medicines that lengthen life, enhance its quality, and avert more expensive medical care. You are the beneficiaries of this ongoing achievement of the American free enterprise system, so be grateful, quit whining, and pay up.” More prosaically, what the industry is saying is that you get what you pay for.
Is any of this true? Well, the first part certainly is. Prescription drug costs are indeed high—and rising fast. Americans now spend a staggering $200 billion a year on prescription drugs, and that figure is growing at a rate of about 12 percent a year (down from a high of 18 percent in 1999).1 Drugs are the fastest-growing part of the health care bill—which itself is rising at an alarming rate. The increase in drug spending reflects, in almost equal parts, the facts that people are taking a lot more drugs than they used to, that those drugs are more likely to be expensive new ones instead of older, cheaper ones, and that the prices of the most heavily prescribed drugs are routinely jacked up, sometimes several times a year.
Before its patent ran out, for example, the price of Schering-Plough’s top-selling allergy pill, Claritin, was raised thirteen times over five years, for a cumulative increase of more than 50 percent—over four times the rate of general inflation.2 As a spokeswoman for one company explained, “Price increases are not uncommon in the industry and this allows us to be able to invest in R&D.”3 In 2002, the average price of the fifty drugs most used by senior citizens was nearly $1,500 for a year’s supply. (Pricing varies greatly, but this refers to what the companies call the average wholesale price, which is usually pretty close to what an individual without insurance pays at the pharmacy.)
This is an industry that in some ways is like the Wizard of Oz—still full of bluster but now being exposed as something far different from its image. Instead of being an engine of innovation, it is a vast marketing machine. Instead of being a free market success story, it lives off government-funded research and monopoly rights. Yet this industry occupies an essential role in the American health care system, and it performs a valuable function, if not in discovering important new drugs at least in developing them and bringing them to market. But big pharma is extravagantly rewarded for its relatively modest functions. We get nowhere near our money’s worth. The United States can no longer afford it in its present form. (The New York Review of Books)
Attorney General Rafael Macedo de la Concha and 160 of his employees were implanted at a cost to taxpayers of $150 for each rice grain-sized chip. More are scheduled to get "tagged" in coming months, and key members of the Mexican military, the police and the office of President Vicente Fox might follow suit, Aceves said. Fox's office did not immediately return a call seeking comment. (Associated Press)
This database has been loaded 1,799,185 times since May 2009.
FAIR USE NOTICE:
This site contains copyrighted material the use of which has not always been specifically
authorized by the copyright owner. We are making such material available in our efforts to advance
understanding of criminal justice, political, human rights, economic, democracy, scientific, and
social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material
as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107,
the material on this site is distributed without profit to those who have expressed a prior interest in
receiving the included information for research and educational purposes. For more information go to:
http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own
that go beyond 'fair use', you must obtain permission from the copyright owner.